MGMT and neoplasm: Moreover, retrospective data showed that sensitivity to TMZ was mainly restricted to pMMR/MSS tumours with complete MGMT protein loss detected with immunohistochemistry as showed in studies assessing the efficacy of TMZ alone or in combination with other chemotherapeutic agents, such as capecitabine and irinotecan [34,35,36].